- Home
- CMPX vs TRTX Comparison
CMPX vs TRTX Comparison
Compare CMPX & TRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- TRTX
- Stock Information
- Founded
- CMPX 2014
- TRTX 2014
- Country
- CMPX United States
- TRTX United States
- Employees
- CMPX N/A
- TRTX N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- TRTX Real Estate Investment Trusts
- Sector
- CMPX Health Care
- TRTX Real Estate
- Exchange
- CMPX Nasdaq
- TRTX Nasdaq
- Market Cap
- CMPX 730.9M
- TRTX 685.3M
- IPO Year
- CMPX N/A
- TRTX 2017
- Fundamental
- Price
- CMPX $4.03
- TRTX $8.90
- Analyst Decision
- CMPX Strong Buy
- TRTX Buy
- Analyst Count
- CMPX 7
- TRTX 3
- Target Price
- CMPX $14.71
- TRTX $9.50
- AVG Volume (30 Days)
- CMPX 1.9M
- TRTX 482.8K
- Earning Date
- CMPX 11-11-2025
- TRTX 10-28-2025
- Dividend Yield
- CMPX N/A
- TRTX 10.82%
- EPS Growth
- CMPX N/A
- TRTX N/A
- EPS
- CMPX N/A
- TRTX 0.65
- Revenue
- CMPX N/A
- TRTX $138,587,000.00
- Revenue This Year
- CMPX N/A
- TRTX N/A
- Revenue Next Year
- CMPX N/A
- TRTX $6.83
- P/E Ratio
- CMPX N/A
- TRTX $13.65
- Revenue Growth
- CMPX N/A
- TRTX 216.02
- 52 Week Low
- CMPX $1.27
- TRTX $6.47
- 52 Week High
- CMPX $4.86
- TRTX $9.85
- Technical
- Relative Strength Index (RSI)
- CMPX 53.07
- TRTX 54.24
- Support Level
- CMPX $3.86
- TRTX $8.50
- Resistance Level
- CMPX $4.86
- TRTX $8.82
- Average True Range (ATR)
- CMPX 0.31
- TRTX 0.15
- MACD
- CMPX -0.05
- TRTX 0.05
- Stochastic Oscillator
- CMPX 38.43
- TRTX 78.99
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About TRTX TPG RE Finance Trust Inc.
TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating rate first mortgage loans that are secured by high quality commercial real estate properties undergoing some form of transition and value creation.